Sun Pharma’s recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known......
Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of......
Patent filings in India would be more and more driven by new technologies, which are either kept secret or patented. In line with this, there will be a big shift towards protection of......
Sun Pharmaceutical Industries Ltd is in talks to buy Swedish drugmaker MedaAB for $5 billion-$6 billion to boost its generics business in developed markets, two sources with direct knowledge of the......
Benchmark Indices are trading on a higher note led by Auto, Metal and Oil & Gas shares.Meanwhile, building confidence that the US will reach a budget deal with Congress to avoid fiscal cliff has......